AAPL337.02-2.73 (-0.80%) ▼|ABBV265.08-0.13 (-0.05%) ▼|ABT103.49-0.20 (-0.19%) ▼|ACN183.52-0.20 (-0.11%) ▼|ADBE240.69+2.44 (+1.02%) ▲|AMAT474.38+1.92 (+0.41%) ▲|AMD614.61-9.16 (-1.47%) ▼|AMGN406.09-4.15 (-1.01%) ▼|AMT170.78-4.47 (-2.55%) ▼|AMZN249.27-5.71 (-2.24%) ▼|AVGO354.99-9.55 (-2.62%) ▼|AXP301.96-3.11 (-1.02%) ▼|BA199.93+2.21 (+1.12%) ▲|BAC56.00-0.20 (-0.36%) ▼|BKNG155.90-8.32 (-5.07%) ▼|BLK1,060.89-5.77 (-0.54%) ▼|BMY61.15-1.10 (-1.77%) ▼|BNY149.51-0.66 (-0.44%) ▼|BRK-B507.17+3.68 (+0.73%) ▲|C131.93-0.54 (-0.41%) ▼|CAT812.02+4.01 (+0.50%) ▲|CL85.93-1.12 (-1.29%) ▼|CMCSA22.55+0.13 (+0.58%) ▲|COF196.10-4.45 (-2.22%) ▼|COP128.09+2.82 (+2.25%) ▲|COST904.70+5.29 (+0.59%) ▲|CRM237.58+4.30 (+1.84%) ▲|CSCO106.43-0.01 (-0.01%) ▼|CVS85.86-1.24 (-1.42%) ▼|CVX205.51+3.10 (+1.53%) ▲|DE709.48+6.36 (+0.90%) ▲|DHR221.56+0.47 (+0.21%) ▲|DIS103.46-0.36 (-0.35%) ▼|DUK114.17-2.14 (-1.84%) ▼|EMR154.59+0.40 (+0.26%) ▲|FDX291.50-4.44 (-1.50%) ▼|GD343.33-0.06 (-0.02%) ▼|GE319.80+0.58 (+0.18%) ▲|GEV951.82+1.54 (+0.16%) ▲|GILD151.37-1.30 (-0.85%) ▼|GM83.77+0.32 (+0.38%) ▲|GOOG334.98-12.43 (-3.58%) ▼|GOOGL337.83-13.33 (-3.80%) ▼|GS936.36-13.13 (-1.38%) ▼|HD296.72-8.63 (-2.83%) ▼|HON212.57+0.72 (+0.34%) ▲|IBM232.76+1.38 (+0.60%) ▲|INTC122.60-1.26 (-1.02%) ▼|INTU286.80-5.55 (-1.90%) ▼|ISRG398.30-3.79 (-0.94%) ▼|JNJ269.17-0.02 (-0.01%) ▼|JPM337.53-2.47 (-0.73%) ▼|KO88.09-0.52 (-0.59%) ▼|LIN469.72+4.81 (+1.03%) ▲|LLY1,150.99-19.15 (-1.64%) ▼|LMT524.68+2.34 (+0.45%) ▲|LOW191.36-4.72 (-2.41%) ▼|LRCX307.28-3.35 (-1.08%) ▼|MA559.92+4.03 (+0.73%) ▲|MCD238.32-12.03 (-4.81%) ▼|MDLZ61.44+0.36 (+0.59%) ▲|MDT89.30-1.47 (-1.62%) ▼|META744.10+7.51 (+1.02%) ▲|MMM170.30+1.00 (+0.59%) ▲|MO68.95+0.31 (+0.45%) ▲|MRK148.08-2.83 (-1.88%) ▼|MS198.39-1.79 (-0.89%) ▼|MSFT500.59+2.59 (+0.52%) ▲|MU1,071.88-24.28 (-2.22%) ▼|NEE77.02-2.24 (-2.83%) ▼|NFLX71.36-0.80 (-1.11%) ▼|NKE36.05-0.05 (-0.14%) ▼|NOW140.78+3.78 (+2.76%) ▲|NVDA225.51-3.36 (-1.47%) ▼|ORCL144.56-4.64 (-3.11%) ▼|PEP130.18-1.01 (-0.77%) ▼|PFE28.18+0.25 (+0.90%) ▲|PG147.39-0.83 (-0.56%) ▼|PLTR191.79+6.80 (+3.68%) ▲|PM190.84+0.61 (+0.32%) ▲|QCOM197.24-1.03 (-0.52%) ▼|RTX192.19+1.20 (+0.63%) ▲|SBUX94.14-0.97 (-1.02%) ▼|SCHW99.50-0.85 (-0.85%) ▼|SO83.47-1.68 (-1.97%) ▼|SPG204.16-1.79 (-0.87%) ▼|T25.30+0.20 (+0.80%) ▲|TMO665.30+6.78 (+1.03%) ▲|TMUS165.66+3.25 (+2.00%) ▲|TSLA380.12+1.22 (+0.32%) ▲|TXN272.62+1.21 (+0.45%) ▲|UBER69.42-0.47 (-0.67%) ▼|UNH371.29-1.66 (-0.45%) ▼|UNP275.53+1.12 (+0.41%) ▲|UPS95.82-0.05 (-0.05%) ▼|USB58.48-0.96 (-1.62%) ▼|V361.52-0.52 (-0.14%) ▼|VZ46.52+0.07 (+0.15%) ▲|WFC81.90-1.25 (-1.50%) ▼|WMT110.53+0.41 (+0.37%) ▲|XOM161.23+2.52 (+1.59%) ▲|AAPL337.02-2.73 (-0.80%) ▼|ABBV265.08-0.13 (-0.05%) ▼|ABT103.49-0.20 (-0.19%) ▼|ACN183.52-0.20 (-0.11%) ▼|ADBE240.69+2.44 (+1.02%) ▲|AMAT474.38+1.92 (+0.41%) ▲|AMD614.61-9.16 (-1.47%) ▼|AMGN406.09-4.15 (-1.01%) ▼|AMT170.78-4.47 (-2.55%) ▼|AMZN249.27-5.71 (-2.24%) ▼|AVGO354.99-9.55 (-2.62%) ▼|AXP301.96-3.11 (-1.02%) ▼|BA199.93+2.21 (+1.12%) ▲|BAC56.00-0.20 (-0.36%) ▼|BKNG155.90-8.32 (-5.07%) ▼|BLK1,060.89-5.77 (-0.54%) ▼|BMY61.15-1.10 (-1.77%) ▼|BNY149.51-0.66 (-0.44%) ▼|BRK-B507.17+3.68 (+0.73%) ▲|C131.93-0.54 (-0.41%) ▼|CAT812.02+4.01 (+0.50%) ▲|CL85.93-1.12 (-1.29%) ▼|CMCSA22.55+0.13 (+0.58%) ▲|COF196.10-4.45 (-2.22%) ▼|COP128.09+2.82 (+2.25%) ▲|COST904.70+5.29 (+0.59%) ▲|CRM237.58+4.30 (+1.84%) ▲|CSCO106.43-0.01 (-0.01%) ▼|CVS85.86-1.24 (-1.42%) ▼|CVX205.51+3.10 (+1.53%) ▲|DE709.48+6.36 (+0.90%) ▲|DHR221.56+0.47 (+0.21%) ▲|DIS103.46-0.36 (-0.35%) ▼|DUK114.17-2.14 (-1.84%) ▼|EMR154.59+0.40 (+0.26%) ▲|FDX291.50-4.44 (-1.50%) ▼|GD343.33-0.06 (-0.02%) ▼|GE319.80+0.58 (+0.18%) ▲|GEV951.82+1.54 (+0.16%) ▲|GILD151.37-1.30 (-0.85%) ▼|GM83.77+0.32 (+0.38%) ▲|GOOG334.98-12.43 (-3.58%) ▼|GOOGL337.83-13.33 (-3.80%) ▼|GS936.36-13.13 (-1.38%) ▼|HD296.72-8.63 (-2.83%) ▼|HON212.57+0.72 (+0.34%) ▲|IBM232.76+1.38 (+0.60%) ▲|INTC122.60-1.26 (-1.02%) ▼|INTU286.80-5.55 (-1.90%) ▼|ISRG398.30-3.79 (-0.94%) ▼|JNJ269.17-0.02 (-0.01%) ▼|JPM337.53-2.47 (-0.73%) ▼|KO88.09-0.52 (-0.59%) ▼|LIN469.72+4.81 (+1.03%) ▲|LLY1,150.99-19.15 (-1.64%) ▼|LMT524.68+2.34 (+0.45%) ▲|LOW191.36-4.72 (-2.41%) ▼|LRCX307.28-3.35 (-1.08%) ▼|MA559.92+4.03 (+0.73%) ▲|MCD238.32-12.03 (-4.81%) ▼|MDLZ61.44+0.36 (+0.59%) ▲|MDT89.30-1.47 (-1.62%) ▼|META744.10+7.51 (+1.02%) ▲|MMM170.30+1.00 (+0.59%) ▲|MO68.95+0.31 (+0.45%) ▲|MRK148.08-2.83 (-1.88%) ▼|MS198.39-1.79 (-0.89%) ▼|MSFT500.59+2.59 (+0.52%) ▲|MU1,071.88-24.28 (-2.22%) ▼|NEE77.02-2.24 (-2.83%) ▼|NFLX71.36-0.80 (-1.11%) ▼|NKE36.05-0.05 (-0.14%) ▼|NOW140.78+3.78 (+2.76%) ▲|NVDA225.51-3.36 (-1.47%) ▼|ORCL144.56-4.64 (-3.11%) ▼|PEP130.18-1.01 (-0.77%) ▼|PFE28.18+0.25 (+0.90%) ▲|PG147.39-0.83 (-0.56%) ▼|PLTR191.79+6.80 (+3.68%) ▲|PM190.84+0.61 (+0.32%) ▲|QCOM197.24-1.03 (-0.52%) ▼|RTX192.19+1.20 (+0.63%) ▲|SBUX94.14-0.97 (-1.02%) ▼|SCHW99.50-0.85 (-0.85%) ▼|SO83.47-1.68 (-1.97%) ▼|SPG204.16-1.79 (-0.87%) ▼|T25.30+0.20 (+0.80%) ▲|TMO665.30+6.78 (+1.03%) ▲|TMUS165.66+3.25 (+2.00%) ▲|TSLA380.12+1.22 (+0.32%) ▲|TXN272.62+1.21 (+0.45%) ▲|UBER69.42-0.47 (-0.67%) ▼|UNH371.29-1.66 (-0.45%) ▼|UNP275.53+1.12 (+0.41%) ▲|UPS95.82-0.05 (-0.05%) ▼|USB58.48-0.96 (-1.62%) ▼|V361.52-0.52 (-0.14%) ▼|VZ46.52+0.07 (+0.15%) ▲|WFC81.90-1.25 (-1.50%) ▼|WMT110.53+0.41 (+0.37%) ▲|XOM161.23+2.52 (+1.59%) ▲|
14.3 C
New York
Thursday, September 24, 2026

Tag: securities

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Civitas, Open Lending, and West Pharmaceutical and...

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Compass Diversified (NYSE:CODI), Civitas Resources, Inc. (NYSE: CIVI), Open Lending Corporation (NASDAQ:LPRO), and West Pharmaceutical Services, Inc. (NYSE:WST). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ibotta, NET Power, Zenas BioPharma, and Avis Budget and...

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Ibotta, Inc. (NYSE:IBTA), NET Power, Inc. (NYSE:NPWR), Zenas BioPharma, Inc. (NASDAQ:ZBIO), and Avis Budget Group, Inc. (NASDAQ:CAR). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

SOUNDHOUND ALERT: Bragar Eagel & Squire, P.C. is Investigating SoundHound AI, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against SoundHound AI, Inc. (NASDAQ:SOUN) on behalf of long-term stockholders following a class action complaint that was filed against SoundHound on March 28, 2025 with a Class Period from May 10, 2024 and March 3, 2025. Our investigation concerns whether the board of directors of SoundHound have breached their fiduciary duties to the company.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Krispy Kreme, Digimarc, Elevance Health, and Iovance and Encourages...

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Krispy Kreme, Inc. (NASDAQ:DNUT), Digimarc Corporation (NASDAQ:DMRC), Elevance Health, Inc. (NYSE:ELV), and Iovance Biotherapeutics, Inc. (NASDAQ:IOVA). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Bragar Eagel & Squire, P.C. Is Investigating Semler, ADTRAN, and Fulgent and Encourages Investors to Contact the Firm

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Semler Scientific Inc. (NASDAQ:SMLR), ADTRAN Holdings, Inc. (NASDAQ:ADTN), and Fulgent Genetics, Inc. (NASDAQ: FLGT). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.

Bell Announces Upsizing and Results of its Cash Tender Offers for Four Series of Debt Securities

This news release contains forward-looking statements. For a description of the related risk factors and assumptions, please see the section entitled "Caution Concerning Forward-Looking...

KERNWOOD LIMITED ANNOUNCES ACQUISITION OF ADDITIONAL SHARES OF WESTERN FOREST PRODUCTS INC.

TORONTO, June 9, 2025 /CNW/ - Kernwood Limited ("Kernwood") reports pursuant to the "Early Warning Requirements" of Canadian securities laws that it purchased 1,000,000...

MediPharm Labs’ Founder-CEO Pat McCutcheon Throws his Support behind Apollo Capital as Dissident

McCutcheon Agrees with Apollo that Urgent Change is Needed, including Complete Turnover at the Board Level after Years of Value-Destruction

Lido Merger Sub, Inc. Announces Extension of Expiration Date of Tender Offer and Consent Solicitation for 8.875% Senior Notes due 2029 of Landsea Homes...

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Lido Merger Sub, Inc. (the “Company”) announced today that it is extending the Expiration Date (as defined below) of its previously announced cash tender offer (the “Tender Offer”) to purchase any and all of Landsea Homes Corporation’s (“Landsea Homes”) outstanding 8.875% Senior Notes due 2029 (the “Notes”) and solicitation of consents of holders of the Notes to certain proposed amendments to the indenture governing the Notes (the “Consent Solicitation”).

Thirteen Studies of Ascentage Pharma’s Assets Including Olverembatinib and Lisaftoclax Selected for Presentations at 2025 European Hematology Association Annual Congress

ROCKVILLE, Md. and SUZHOU, China, June 09, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that 13 studies of its core assets - including the novel drug olverembatinib (HQP1351), the investigational Bcl-2 inhibitor lisaftoclax (APG-2575), and the investigational EED inhibitor APG-5918 – will be featured in an oral presentation, multiple poster presentations and multiple online publications at the 2025 European Hematology Association (EHA) Annual Congress taking place in Milan, Italy, from June 12-15, 2025.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KNW and HLGN on Behalf of Shareholders

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HURA and VIGL on Behalf of Shareholders

NEW YORK, June 9, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPOF, PRA, SWTX on Behalf of Shareholders

NEW YORK, June 9, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of...

Five Star Bank expands Bay Area presence with new office in Walnut Creek

Strategic growth reflects Five Star Bank’s commitment to bringing concierge commercial banking services to East Bay businesses, entrepreneurs, and non-profits
Strategic growth reflects Five Star Bank’s commitment to bringing concierge commercial banking services to East Bay businesses, entrepreneurs, and non-profits

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSecurities